Pegylated interferon alpha 2a is an effective and well‐tolerated treatment option for lymphocyte‐variant hypereosinophilic syndrome
Autor: | Nadia Medvedev, Jan P. Dutz, Daniel Moller, Luke Y.C. Chen, Julia Tan, Erica A. Peterson, Carol Dou, Charles Choi, Mollie N. Carruthers |
---|---|
Rok vydání: | 2019 |
Předmět: |
Adult
Aged 80 and over Male business.industry Hypereosinophilic syndrome Lymphocyte Interferon-alpha Alpha interferon Treatment options Hematology Middle Aged Eosinophil medicine.disease Recombinant Proteins Polyethylene Glycols medicine.anatomical_structure Pegylated interferon alpha 2a Hypereosinophilic Syndrome Immunology Humans Medicine Female business Aged Follow-Up Studies |
Zdroj: | British Journal of Haematology. 188 |
ISSN: | 1365-2141 0007-1048 |
Databáze: | OpenAIRE |
Externí odkaz: |